The Involvement of Norepinephrine in Behaviors Related to Psychostimulant AddictionOxidative Stress in Neurodegenerative DiseasesInfluence of Pharmacotherapy on Cognitive Functions in Depression: A Review of the LiteratureUnderstanding the Functional Plasticity in Neural Networks of the Basal Ganglia in Cocaine Use Disorder: A Role for Allosteric Receptor-Receptor Interactions in A2A-D2 Heteroreceptor ComplexesAntagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysisLong-term abstinence from developmental cocaine exposure alters Arc/Arg3.1 modulation in the rat medial prefrontal cortexIncrease in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal.Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structuresCocaine Administration and Its Withdrawal Enhance the Expression of Genes Encoding Histone-Modifying Enzymes and Histone Acetylation in the Rat Prefrontal Cortex.Effect of serotonin (5-HT)1B receptor ligands on cocaine sensitization in rats.Effects of GABAB receptor agonists on cocaine hyperlocomotor and sensitizing effects in rats.Serotonin 5-HT(2C) receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine.Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex.GPCR heteromers and their allosteric receptor-receptor interactions.Role of serotonin 5-HT1B receptors in psychostimulant addiction.Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on the locomotor and sensitizating effects of cocaine in rats.Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses.Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats.GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators.Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats.Psychostimulants: Basic and Clinical Pharmacology.The endocannabinoid/endovanilloid system and depression.Effects of GABA(B) receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination.Effects of GABAB receptor ligands in animal tests of depression and anxiety.Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology.A comprehensive view of the epigenetic landscape part I: DNA methylation, passive and active DNA demethylation pathways and histone variants.Effects of serotonin (5-HT)(1B) receptor ligands on cocaine-seeking behavior in rats.A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs.On the role of A₂A and D₂ receptors in control of cocaine and food-seeking behaviors in rats.Cocaine self-administration in Wistar-Kyoto rats: a behavioral and biochemical analysis.Cysteine Metabolism and Oxidative Processes in the Rat Liver and Kidney after Acute and Repeated Cocaine Treatment.The effect of UV-filters on the viability of neuroblastoma (SH-SY5Y) cell line.A novel mechanism of cocaine to enhance dopamine d2-like receptor mediated neurochemical and behavioral effects. An in vivo and in vitro studyUnderstanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and DiseaseThe serotonergic system and its role in cocaine addiction.Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?Oxidative stress biomarkers in some rat brain structures and peripheral organs underwent cocaineGlutamate transporters in brain ischemia: to modulate or not?N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression.The effects of cocaine on different redox forms of cysteine and homocysteine, and on labile, reduced sulfur in the rat plasma following active versus passive drug injections.
P50
Q26786261-DB7C6C38-03EF-4B9A-8984-63D4B97BC100Q26801239-87453544-992A-42BA-BC17-3D08697DCC53Q27694555-3FFB7F26-C333-47D8-9D34-3EBD692EC9D1Q28071958-6653BA2D-3973-4B4C-AFFC-AB893AD1D01CQ28268078-BD3D9D57-B97A-466B-9F3E-0C1A3B7525DEQ28771392-09BCD123-BA0D-46FB-9BD3-34A21BEA69B7Q33275374-144FF69D-1BE1-443B-B066-1F046A328CA1Q33794471-80806889-90A9-4BB1-B607-7E6D9B721FACQ33844424-138E2EDB-F513-419A-A505-CDC6C1D7DA90Q33950394-A6CBF9C3-98E5-41E7-9902-21CC9067C84BQ34093322-A2AE9A6B-E393-49EC-BD37-8638D3185BFCQ34117803-9A80B7A8-E47E-4459-AEB1-83B6C688908BQ34193683-6F0E583C-F4B3-4F04-9879-E3544AA91CE0Q34254454-385505EB-2BC2-457C-9909-D96402ACC7A9Q34256422-2C83A016-67EE-46D6-8B94-2A2959043618Q34310065-71768C8F-29E8-449E-B9BD-C2FBB74A1293Q34319268-55563399-BF7E-4BA8-85E5-3D3A8B71A2B9Q34413520-C4951CE9-675B-4C04-9E4B-4E9F92E6FCE7Q34426765-4156AEB6-1724-4481-9A4D-249C47337BF6Q34464229-2E430B38-4E7E-4849-9209-383B9EFBF913Q34480564-395D7029-9272-4250-A614-55B14CBFB003Q34567576-57C7EB65-DF9F-4DB4-BA7F-DC2B9B4159CEQ34663012-A255F97D-323E-424E-9A52-115E7C6C322EQ34736202-C8CCBFEE-BAA2-4638-9D27-4C2EEC82AF01Q34742184-2B4D2844-7764-4ED7-9340-74986D05EA38Q34855021-E3CAD1DD-0DBF-4F8E-A1AD-5D51F4F7FDE5Q34943339-452DF0F5-564B-4787-9F30-58500B43F29EQ34990282-EA4A9BE9-3C1F-47ED-9C99-F7F2A1743227Q35539454-571F92B1-A3E6-477D-B2ED-05A4DC92BA7BQ35699300-7F0A1B02-934A-47D8-9244-76F34DFF8753Q35903690-7E38FB55-7F4A-4A9C-B053-CF9E02868B26Q35953143-061B590B-BD15-47DF-9FA4-D9C66E54DE8DQ36035907-FCBF93F9-FD30-4CD1-BE03-87DAA804280CQ36300230-60789484-D444-4F25-A786-7540E332D733Q36355234-6F214321-4145-44BD-A3D5-2F7AA9E77F9AQ36431393-5D2F5D16-3F3F-4B3E-A799-8803DE8CADF6Q36479087-E5E6F32E-3408-412D-BB48-0C5B05F7BAD3Q36745208-C8742B6C-3C9F-4443-8DC4-BC26E01EE1D7Q36764301-253DAFB0-11AD-4034-A435-24103FFCADC4Q37121626-9D7A86F1-DDED-40AC-BDDA-4B6D39140C27
P50
description
Pools onderzoekster
@nl
polska profesor nauk farmaceutycznych, specjalistka w dziedzinie farmakologii
@pl
researcher ORCID ID = 0000-0002-4321-7942
@en
name
M Filip
@ast
M Filip
@es
M Filip
@nl
Małgorzata Filip
@ca
Małgorzata Filip
@cs
Małgorzata Filip
@en
Małgorzata Filip
@ga
Małgorzata Filip
@gl
Małgorzata Filip
@hr
Małgorzata Filip
@hsb
type
label
M Filip
@ast
M Filip
@es
M Filip
@nl
Małgorzata Filip
@ca
Małgorzata Filip
@cs
Małgorzata Filip
@en
Małgorzata Filip
@ga
Małgorzata Filip
@gl
Małgorzata Filip
@hr
Małgorzata Filip
@hsb
altLabel
M Filip
@en
Malgorzata Filip
@en
Małgorzata Maria Filip
@pl
prefLabel
M Filip
@ast
M Filip
@es
M Filip
@nl
Małgorzata Filip
@ca
Małgorzata Filip
@cs
Małgorzata Filip
@en
Małgorzata Filip
@ga
Małgorzata Filip
@gl
Małgorzata Filip
@hr
Małgorzata Filip
@hsb
P214
P106
P1153
55410836400
P1207
P1412
P1559
Małgorzata Filip
@pl
P21
P213
0000 0001 1412 1143
P214
P27
P31
P3124
P496
0000-0002-4321-7942
P7293
9810675860705606
P734
P735
P7859
viaf-311126163